CID 470304

7-[4-[[(3z)-5-bromo-2-oxo-3-[4-(pyrimidin-2-ylsulfamoyl)phenyl]imino-indolin-1-yl]methyl]piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid

Structural Information

Molecular Formula
C35H30BrFN8O6S
SMILES
CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)CN4C5=C(C=C(C=C5)Br)C(=NC6=CC=C(C=C6)S(=O)(=O)NC7=NC=CC=N7)C4=O)F)C(=O)O
InChI
InChI=1S/C35H30BrFN8O6S/c1-2-43-19-26(34(48)49)32(46)25-17-27(37)30(18-29(25)43)44-14-12-42(13-15-44)20-45-28-9-4-21(36)16-24(28)31(33(45)47)40-22-5-7-23(8-6-22)52(50,51)41-35-38-10-3-11-39-35/h3-11,16-19H,2,12-15,20H2,1H3,(H,48,49)(H,38,39,41)
InChIKey
LKLFDCNAKYKMIH-UHFFFAOYSA-N
Compound name
7-[4-[[5-bromo-2-oxo-3-[4-(pyrimidin-2-ylsulfamoyl)phenyl]iminoindol-1-yl]methyl]piperazin-1-yl]-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

788.1176 Da
Monoisotopic Mass

2.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 789.12488 256.1
[M+Na]+ 811.10682 262.4
[M-H]- 787.11032 266.1
[M+NH4]+ 806.15142 250.2
[M+K]+ 827.08076 250.1
[M+H-H2O]+ 771.11486 250.0
[M+HCOO]- 833.11580 257.3
[M+CH3COO]- 847.13145 259.0
[M+Na-2H]- 809.09227 256.8
[M]+ 788.11705 274.1
[M]- 788.11815 274.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.